Shopping Cart
Remove All
Your shopping cart is currently empty
Romosozumab
😃Good
Catalog No. T77380Cas No. 909395-70-6
Alias CDP-7851, CDP7851, AMG-785, AMG785
Romosozumab (AMG-785) is a humanized monoclonal antibody that binds and inhibits sclerostin, increasing bone formation and decreasing bone resorption.Romosozumab is used in the study of postmenopausal osteoporosis.
Romosozumab
Romosozumab
😃Good
Catalog No. T77380Alias CDP-7851, CDP7851, AMG-785, AMG785Cas No. 909395-70-6
Romosozumab (AMG-785) is a humanized monoclonal antibody that binds and inhibits sclerostin, increasing bone formation and decreasing bone resorption.Romosozumab is used in the study of postmenopausal osteoporosis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $232 | - | In Stock | |
| 5 mg | $581 | - | In Stock | |
| 10 mg | $930 | - | In Stock | |
| 25 mg | $1,581 | - | In Stock | |
| 50 mg | $2,370 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:98.9% (SDS-PAGE); 98.2% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Romosozumab (AMG-785) is a humanized monoclonal antibody that binds and inhibits sclerostin, increasing bone formation and decreasing bone resorption.Romosozumab is used in the study of postmenopausal osteoporosis. |
| In vivo | Romosozumab (30 mg/kg twice weekly for 10 weeks) induces the transformation of bone trabecular rod-like structures to plate-like structures in cynomolgus monkeys. [1] In mature cynomolgus monkeys undergoing ovariectomy for 4 months, Romosozumab (3 mg/kg and 30 mg/kg once weekly for 6 or 12 months) was able to enhance bone mass, optimize bone structure, and improve bone strength while maintaining bone quality. [2] |
| Synonyms | CDP-7851, CDP7851, AMG-785, AMG785 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | SOST/Sclerostin |
| Molecular Weight | 145.87 kDa |
| Cas No. | 909395-70-6 |
| Isotype | Human IgG2 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Romosozumab | purchase Romosozumab | Romosozumab cost | order Romosozumab | Romosozumab in vivo | Romosozumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.